RESUMEN
Hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (AHSCT) in both children and adults has been associated with significant morbidity and mortality. Early HC can occur within 48 hours of completing the chemotherapy conditioning regimen, is usually associated with agents such as cyclophosphamide, and generally resolves promptly. Late HC is commonly associated with BK and other viruses and can prove refractory to antiviral and supportive therapy. There are limited reports of hyperbaric oxygen (HBO2) therapy showing benefit for refractory HC cases. We describe our experience with salvage HBO2 for a 15-year-old male with refractory HC beginning one month post AHSCT and associated with BK virus. Despite supportive therapies including hyperhydration, forced diuresis, transfusions, intravenous and intravesical cidofovir, macroscopic hematuria persisted and resulted in post-obstructive acute renal failure, need for a suprapubic catheter, then bilateral percutaneous nephrostomy tubes. HBO2 was started two months after the AHSCT and one month after detection of BK viremia. In the week prior to starting HBO2 therapy the patient required transfusion with 25 units of red blood cells and seven units of platelets. After HBO2 was started his transfusion requirements progressively decreased, and he had return of renal function. He had no adverse effect from the HBO2. HBO2 therapy could thus be useful in controlling refractory HC after AHSCT.
Asunto(s)
Cistitis/terapia , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Hemorragia/terapia , Oxigenoterapia Hiperbárica , Terapia Recuperativa/métodos , Lesión Renal Aguda/etiología , Adolescente , Antivirales/uso terapéutico , Virus BK , Cidofovir/uso terapéutico , Cistitis/etiología , Transfusión de Eritrocitos/estadística & datos numéricos , Hemorragia/etiología , Humanos , Masculino , Infecciones por Polyomavirus/complicaciones , Infecciones Tumorales por Virus/complicacionesRESUMEN
Background: A nontoxic chemopreventive intervention efficacious against different subtypes of breast cancer is still a clinically unmet need. The present study was undertaken to determine the efficacy of an Ayurvedic medicine phytochemical (Withaferin A, [WA]) for chemoprevention of breast cancer and to elucidate its mode of action. Methods: Chemopreventive efficacy of WA (4 and 8 mg/kg body weight) was determined using a rat model of breast cancer induced by N-methyl-N-nitrosourea (MNU; n = 14 for control group, n = 15 for 4 mg/kg group, and n = 18 for 8 mg/kg group). The mechanisms underlying breast cancer chemoprevention by WA were elucidated by immunoblotting, biochemical assays, immunohistochemistry, and cytokine profiling using plasma and tumors from the MNU-rat (n = 8-12 for control group, n = 7-11 for 4 mg/kg group, and n = 8-12 for 8 mg/kg group) and/or mouse mammary tumor virus-neu (MMTV-neu) models (n = 4-11 for control group and n = 4-21 for 4 mg/kg group). Inhibitory effect of WA on exit from mitosis and leptin-induced oncogenic signaling was determined using MCF-7 and/or MDA-MB-231 cells. All statistical tests were two-sided. Results: Incidence, multiplicity, and burden of breast cancer in rats were decreased by WA administration. For example, the tumor weight in the 8 mg/kg group was lower by about 68% compared with controls (8 mg/kg vs control, mean = 2.76 vs 8.59, difference = -5.83, 95% confidence interval of difference = -9.89 to -1.76, P = .004). Mitotic arrest and apoptosis induction were some common determinants of breast cancer chemoprevention by WA in the MNU-rat and MMTV-neu models. Cytokine profiling showed suppression of plasma leptin levels by WA in rats. WA inhibited leptin-induced oncogenic signaling in cultured breast cancer cells. Conclusions: WA is a promising chemopreventative phytochemical with the ability to inhibit at least two different subtypes of breast cancer.
Asunto(s)
Neoplasias de la Mama/prevención & control , Neoplasias Mamarias Experimentales/prevención & control , Virus del Tumor Mamario del Ratón , Infecciones por Retroviridae/complicaciones , Infecciones Tumorales por Virus/complicaciones , Witanólidos/uso terapéutico , 8-Hidroxi-2'-Desoxicoguanosina , Acetilcoenzima A/sangre , Familia de Aldehído Deshidrogenasa 1 , Animales , Apoptosis/efectos de los fármacos , Biomarcadores de Tumor/análisis , Neoplasias de la Mama/inducido químicamente , Neoplasias de la Mama/química , Neoplasias de la Mama/patología , Ciclo Celular/efectos de los fármacos , Citocinas/sangre , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análisis , Complejo III de Transporte de Electrones/metabolismo , Femenino , Factores de Transcripción Forkhead/análisis , Humanos , Antígeno Ki-67/análisis , Ácido Láctico/sangre , Leptina/sangre , Células MCF-7 , Malatos/sangre , Neoplasias Mamarias Experimentales/química , Neoplasias Mamarias Experimentales/patología , Neoplasias Mamarias Experimentales/virología , Metilnitrosourea , Ratones , Mitosis/efectos de los fármacos , Índice Mitótico , Ratas , Receptores de Estrógenos/análisis , Retinal-Deshidrogenasa/análisis , Transducción de Señal/efectos de los fármacos , Carga Tumoral , Witanólidos/análisis , Witanólidos/farmacologíaRESUMEN
BK virus-associated hemorrhagic cystitis (BKV-HC) is a common and major cause of morbidity in recipients of allogeneic hematopoietic stem cell transplantation. A 32-year-old woman developed severe BKV-HC on day 24 after cord blood transplantation (CBT). Despite supportive therapies - such as hyperhydration, forced diuresis, and urinary catheterization - macroscopic hematuria and bladder irritation persisted for over a month. Hyperbaric oxygen (HBO) therapy at 2.1 atmospheres for 90 min per day was started on day 64 after CBT. Macroscopic hematuria resolved within a week, and microscopic hematuria was no longer detectable within 2 weeks. Hematuria did not recur after 11 sessions of HBO therapy, and no significant side effects were observed during or after treatment. HBO therapy could thus be useful in controlling refractory BKV-HC after CBT.
Asunto(s)
Virus BK , Cistitis/terapia , Sangre Fetal/trasplante , Hematuria/terapia , Oxigenoterapia Hiperbárica , Infecciones por Polyomavirus/complicaciones , Infecciones Tumorales por Virus/complicaciones , Adulto , Cistitis/virología , Femenino , Hematuria/virología , Humanos , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapiaRESUMEN
There seems to be little doubt that organosulfur compounds have enormous benefits for biological processes, especially those of diseases like cancer. The preliminary results herein define a cancer model in which benefits/mechanisms of multitudes of xenobiotic and nature's organosulfurs could easily be compared. Mice from three strains with a high incidence for naturally occurring tumors were treated daily with 2-mercaptoethanol (2-Me) starting at weaning. The 100% tumor incidence of undefined etiology in untreated BXSB-Yaa (+) males was completely prevented by 2-Me. In contrast, 2-Me treatment of female and male C3H.OL and C3H.OH congenic strains, did not change the 100% tumor incidence due to milk-borne retrovirus, MMTV(S), but did: (1) delay the appearance of tumors by 42%; (2) increase longevity 56%; and (3) increase longevity, post-tumor detection, 95%. The addition of these results to the increasingly impressive anti-cancer benefits of simple xenobiotic organosulfurs raise the question: Can they be adapted for use as a preventive modality for human cancer?
Asunto(s)
Anticarcinógenos/administración & dosificación , Neoplasias Mamarias Experimentales/prevención & control , Virus del Tumor Mamario del Ratón , Mercaptoetanol/administración & dosificación , Infecciones por Retroviridae/complicaciones , Infecciones Tumorales por Virus/complicaciones , Administración Oral , Animales , Suplementos Dietéticos , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Masculino , Neoplasias Mamarias Experimentales/virología , Ratones , Ratones Endogámicos C3H , Ratones Transgénicos , Resultado del TratamientoRESUMEN
Globally, hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection leads to liver fibrosis and cirrhosis, which in turn causes resultant hepatocellular carcinoma (HCC). Frequently, HCC recurs very soon even after a potentially curative treatment such as surgical interference or locoregional ablative therapies. Chronic HBV/HCV infection is often responsible for this recurrence, through secondary carcinogenesis. Antiviral therapy after a curative treatment of HCC plays an important role in preventing or delaying recurrence and improves survival in patients with HBV/HCV infection-related HCC. This article reviews the worldwide epidemiology of HBV/HCV infection, the association of viral infection with HCC, the mechanism of hepatitis virus-related hepatocarcinogenesis, and the paramount importance of antiviral therapy in the management of HCC.
Asunto(s)
Antivirales/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Hepatitis B Crónica/tratamiento farmacológico , Hepatitis C Crónica/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Infecciones Tumorales por Virus/tratamiento farmacológico , Antineoplásicos/uso terapéutico , Apoptosis , Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/cirugía , Carcinoma Hepatocelular/virología , Portador Sano/epidemiología , Transformación Celular Viral , Terapia Combinada , Terapias Complementarias , Quimioterapia Combinada , Regulación Viral de la Expresión Génica , Hepacivirus/genética , Hepacivirus/patogenicidad , Hepatectomía , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/patogenicidad , Hepatitis B Crónica/complicaciones , Hepatitis B Crónica/epidemiología , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/epidemiología , Interacciones Huésped-Patógeno , Humanos , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/cirugía , Neoplasias Hepáticas/virología , Prevención Secundaria , Infecciones Tumorales por Virus/complicaciones , Integración ViralRESUMEN
Esophageal cancer is one of the most common cancers worldwide. It is a multifactorial disease, and no single agent has been identified so far as the sole cause of the cancer. Many factors like smoking, the consumption of alcohol, fungal-contaminated, spicy and various nitrosamine-containing food stuffs and hot beverages, nutritional deficiency of some vitamins like ß-carotene, vitamin A, C and E and minerals like zinc, selenium and molybdenum, the use of opium, HPV infection and various genetic factors have been found associated with the occurrence of the disease worldwide. Wide geographic differences and substantial changes in the incidence of esophageal cancer occurring over time have been suggested. Among the risk factors in India, betel quid chewing carries a relatively high risk. High incidences in Kashmir have been associated with the consumption of hot salted tea, sun-dried, smoked foods, tobacco in the form of hukka and various genetic factors. The exact cause of esophageal squamous cell carcinoma is unknown. Much work has been carried out on the role of various environmental factors, gene mutations, and polymorphisms worldwide, including Kashmir. Although the Kashmir valley is present on the border of the 'high risk esophageal cancer belt' and esophageal squamous cell carcinoma represents the most commonly occurring malignancy in Kashmir, the amount of information available on various associated factors is still very little as there is a paucity of various epidemiological and molecular studies being carried out in this field.
Asunto(s)
Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/etiología , Neoplasias Esofágicas/epidemiología , Neoplasias Esofágicas/etiología , Consumo de Bebidas Alcohólicas/efectos adversos , Alphapapillomavirus , Apoptosis/genética , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/genética , Enfermedad Crónica , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/genética , Esofagitis/complicaciones , Conducta Alimentaria , Contaminación de Alimentos , Genes Supresores de Tumor , Predisposición Genética a la Enfermedad , Salud Global , Humanos , Incidencia , India/epidemiología , Nitrosaminas/efectos adversos , Oncogenes , Infecciones por Papillomavirus/complicaciones , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Fumar/efectos adversos , Té/efectos adversos , Infecciones Tumorales por Virus/complicaciones , XenobióticosRESUMEN
PURPOSE: To review the current literature as it pertains to hemorrhagic cystitis (HC) in the pediatric bone-marrow transplant (BMT) population. By reviewing the pathophysiology of the disease, preventive methods, and therapeutic options, urologists may be better equipped to manage this challenging clinical scenario. MATERIALS AND METHODS: The HC literature was reviewed using a MEDLINE/PubMed literature search, specifically focusing on the pediatric BMT population as it pertains to the incidence, pathophysiology, prevention, and treatment of HC. RESULTS: Conservative estimates of HC incidence in recent retrospective studies of pediatric BMT populations still approach 10-20%. Several high-volume pediatric BMT centers have reported contemporary data on their experience with HC providing increased insight into incidence and pathophysiology. Accumulating evidence linking BK virus to HC is a significant development warranting further investigation. Other contributing agents/risk factors need identification in the likely multifactorial etiology of HC. Preventive and therapeutic strategies have made modest advances, but certainly need further validation with prospective randomized studies. CONCLUSIONS: Pediatric BMT patients are susceptible for HC development despite preventive measures and improved insight into the pathophysiology. Unfortunately, there are no evidence-based treatment guidelines for this difficult clinical issue that frequently requires prolonged care and multiple treatment modalities necessitating judicious patience in the application of more aggressive interventions.
Asunto(s)
Cistitis/fisiopatología , Cistitis/terapia , Hemorragia/fisiopatología , Hemorragia/terapia , Virus BK , Trasplante de Médula Ósea , Niño , Cistitis/prevención & control , Hemorragia/prevención & control , Humanos , Oxigenoterapia Hiperbárica , Infecciones por Polyomavirus/complicaciones , Infecciones por Polyomavirus/terapia , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/terapiaRESUMEN
Hemorrhagic cystitis is a common complication in hematopoietic stem cell transplant recipients. We report here a case of severe BKV-associated hemorrhagic cystitis who did not respond to intravenous cidofovir. Overt hematuria successfully resolved after a few days on hyperbaric oxygen and intravesical instillations of cidofovir, while BK viruria dropped after a few weeks and remained low. We review the literature for therapeutic options in hemorrhagic cystitis and try to explain how hyperbaric oxygen stimulates mucosal repair in the urinary bladder.
Asunto(s)
Antivirales/administración & dosificación , Cistitis/terapia , Citosina/análogos & derivados , Oxigenoterapia Hiperbárica , Organofosfonatos/administración & dosificación , Administración Intravesical , Adulto , Antineoplásicos/efectos adversos , Virus BK , Cidofovir , Cistitis/etiología , Infecciones por Citomegalovirus/terapia , Citosina/administración & dosificación , Trasplante de Células Madre Hematopoyéticas , Hematuria/etiología , Hematuria/terapia , Humanos , Leucemia Mieloide Aguda/terapia , Leucemia Mieloide Aguda/virología , Masculino , Infecciones por Polyomavirus/complicaciones , Infecciones por Polyomavirus/terapia , Infecciones por Polyomavirus/orina , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/terapia , Infecciones Tumorales por Virus/orinaRESUMEN
OBJECTIVE: The paper presents the role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 and CIN2 with concurrent HPV infection. MATERIAL AND METHODS: Clinical material consisted of 96 women aged 18-52 years of life. The women were divided into three groups. Group A (35 women) treated with Iscador QuS administered s.c. twice a week for 3 months, group B (30 women) treated with Intron A, administered twice a week in the cervical injections for 3 months and control group K (31 women) without treatment followed up with cytology and colposcopy. RESULTS: In the group A (Iscador QuS) CIN remission was observed in slightly higher percentage (non significant) comparing to the control group. In the group B (Intron A) remission CIN was observed in 24 (80%) cases which was statistically significant comparing to the control and A groups. There were no progression of CIN in the group B and the stationery process was observed statistically more frequent comparing to the control and A groups. There was observed statistically higher percentage of cases without HPV infection in all groups during the experiment. The remission concerned both high and low oncogenic potency viruses. In the highest percentage CIN with concurrent HPV infection remission was observed in the B (Intron A) group. CONCLUSIONS: 1/Iscador QuS and specially Intron A increases the CIN1 and CIN2 remission rate. 2/These two agents may also affect the HPV remission.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antineoplásicos Fitogénicos/uso terapéutico , Antivirales/uso terapéutico , Interferón-alfa/uso terapéutico , Infecciones por Papillomavirus/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Proteínas de Plantas/uso terapéutico , Infecciones Tumorales por Virus/tratamiento farmacológico , Displasia del Cuello del Útero/tratamiento farmacológico , Neoplasias del Cuello Uterino/tratamiento farmacológico , Adulto , Colposcopía , Femenino , Humanos , Interferón alfa-2 , Persona de Mediana Edad , Papillomaviridae , Infecciones por Papillomavirus/complicaciones , Proteínas Recombinantes , Inducción de Remisión , Factores de Tiempo , Resultado del Tratamiento , Infecciones Tumorales por Virus/complicaciones , Neoplasias del Cuello Uterino/virología , Displasia del Cuello del Útero/virologíaRESUMEN
A 9-year-old black girl with vertically acquired human immunodeficiency virus (HIV) and no history of condyloma acuminata presented with a 4-year history of enlarging and spreading dark brown flat papules in the perineum. Some of the lesions were confluent and extended from the clitoris to the labia majora and posteriorly to the buttocks and perianal region. A biopsy of one of the lesions showed bowenoid features. Our patient had a normal Pap smear, but vaginal and cervical biopsy specimens revealed human papillomavirus type 16. Therapy with topical imiquimod cream every other day was started, but little improvement was noted after 2 months. Application of 25% podophyllin every 4 to 8 weeks was added, and improvement was noted within 1 month. After 1 year of treatment, the patient had complete resolution of all lesions, and she has had no further appearance of lesions. Our case emphasizes the need for increased awareness of the potential for development of bowenoid papulosis in HIV-positive children as well as the successful treatment of our patient with topical therapy alone.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Antineoplásicos Fitogénicos/uso terapéutico , Enfermedad de Bowen/tratamiento farmacológico , Infecciones por Papillomavirus/complicaciones , Neoplasias Cutáneas/tratamiento farmacológico , Infecciones Tumorales por Virus/complicaciones , Neoplasias de la Vulva/tratamiento farmacológico , Síndrome de Inmunodeficiencia Adquirida/transmisión , Adulto , Aminoquinolinas/uso terapéutico , Antineoplásicos Fitogénicos/administración & dosificación , Enfermedad de Bowen/etiología , Enfermedad de Bowen/virología , Niño , Femenino , Humanos , Imiquimod , Transmisión Vertical de Enfermedad Infecciosa , Intercambio Materno-Fetal , Papillomaviridae/clasificación , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/transmisión , Perineo , Podofilino/administración & dosificación , Podofilino/uso terapéutico , Embarazo , Complicaciones Infecciosas del Embarazo/virología , Inducción de Remisión , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/virología , Infecciones Tumorales por Virus/transmisión , Neoplasias de la Vulva/etiología , Neoplasias de la Vulva/virologíaRESUMEN
OBJECTIVE: Human immunodeficiency virus (HIV)-infected women are at risk for cervical intraepithelial neoplasia (CIN) and cancer due to impaired immunosurveillance over human papillomavirus (HPV) infection. Life stress has been implicated in immune decrements in HIV-infected individuals and therefore may contribute to CIN progression over time. The purpose of this study was to determine whether life stress was associated with progression and/or persistence of squamous intraepithelial lesions (SIL), the cytologic diagnosis conferred by Papanicolaou smear, after 1-year follow-up among women co-infected with HIV and HPV. METHOD: Thirty-two HIV-infected African-American and Caribbean-American women underwent a psychosocial interview, blood draw, colposcopy, and HPV cervical swab at study entry. Using medical chart review, we then abstracted SIL diagnoses at study entry and after 1-year follow-up. RESULTS: Hierarchical logistic regression analysis revealed that higher life stress increased the odds of developing progressive/persistent SIL over 1 year by approximately seven-fold after covarying relevant biological and behavioral control variables. CONCLUSIONS: These findings suggest that life stress may constitute an independent risk factor for SIL progression and/or persistence in HIV-infected women. Stress management interventions may decrease risk for SIL progression/persistence in women living with HIV.
Asunto(s)
Infecciones por VIH/complicaciones , Vigilancia Inmunológica , Papillomaviridae , Infecciones por Papillomavirus/complicaciones , Estrés Psicológico/complicaciones , Infecciones Tumorales por Virus/complicaciones , Displasia del Cuello del Útero/etiología , Neoplasias del Cuello Uterino/etiología , Negro o Afroamericano/psicología , Pruebas Inmunológicas de Citotoxicidad , Progresión de la Enfermedad , Femenino , Florida/epidemiología , Grupos Focales , Infecciones por VIH/inmunología , Infecciones por VIH/psicología , Humanos , Huésped Inmunocomprometido , Acontecimientos que Cambian la Vida , Subgrupos Linfocitarios , Recurrencia Local de Neoplasia , Infecciones por Papillomavirus/inmunología , Infecciones por Papillomavirus/psicología , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/psicología , Estudios Prospectivos , Psiconeuroinmunología , Factores de Riesgo , Factores Socioeconómicos , Estrés Psicológico/inmunología , Infecciones Tumorales por Virus/inmunología , Infecciones Tumorales por Virus/psicología , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/inmunología , Neoplasias del Cuello Uterino/psicología , Indias Occidentales/etnología , Displasia del Cuello del Útero/epidemiología , Displasia del Cuello del Útero/psicologíaRESUMEN
OBJECTIVE: To explore the relationship between serum selenium and cervical cancer. METHODS: We conducted a case-control study of cervical cancer in five areas around Birmingham, AL; Chicago, IL; Denver, CO; Miami, FL; and Philadelphia, PA. Community controls were selected by random-digit dialing and were matched to invasive cervical cancer cases by age, race/ethnicity, and telephone exchange. Serum selenium was determined by neutron activation analysis. Logistic regression analysis controlling for known risk factors of cervical cancer, including human papillomavirus (HPV) type-16 measured serologically, was performed on 227 invasive cases, 127 in-situ cases, and 526 controls. RESULTS: Values of serum selenium ranged from 67.5 to 185.0 ng/ml. Adjusted odds ratios for invasive cervical cancer by quintile were: 1.0 (highest selenium), 1.1, 1.0, 0.8, and 1.0 (lowest selenium), p for trend = 0.82. Similar patterns were observed for Stage I invasive, and Stages II-IV invasive cases, suggesting severity of disease did not influence the null results. Although no associations were seen among current or never smokers, a protective effect of selenium was suggested among former smokers. Effect modification was not evident for other variables examined. CONCLUSIONS: This study does not support a relationship between serum selenium and invasive cervical cancer at typical serum selenium levels in the US.
Asunto(s)
Antioxidantes/metabolismo , Infecciones por Papillomavirus/sangre , Selenio/sangre , Infecciones Tumorales por Virus/sangre , Neoplasias del Cuello Uterino/sangre , Adulto , Anciano , Estudios de Casos y Controles , Intervalos de Confianza , Femenino , Humanos , Persona de Mediana Edad , Oportunidad Relativa , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/epidemiología , Análisis de Regresión , Factores de Riesgo , Fumar/efectos adversos , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/epidemiología , Estados Unidos/epidemiología , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/virologíaRESUMEN
OBJECTIVE: Cervical carcinoma is a human papillomavirus (HPV)-associated cancer for which treatment options still mainly rely on surgical procedures, with or without adjuvant radiotherapy and chemotherapy. As iron may participate in the pathogenesis of viral infections and cancer in several ways, the present study was designed to investigate the effect of iron chelation on HPV-16- and HPV-18-positive cervical carcinoma cell lines. METHODS: Desferrioxamine and deferiprone, two chemically unrelated iron chelators, were used to investigate the effect of iron chelation on SiHa and HeLa cells. Proliferation was investigated by cells counts, by [(3)H]thymidine uptake assay, and by immunostaining with Ki-67 and proliferating cell nuclear antigen (PCNA). Apoptosis was determined by morphological analysis, by a TUNEL assay, and by flow cytometry detecting FITC-conjugated annexin-V. RESULTS: Desferrioxamine and deferiprone induced a time- and dose-dependent inhibition of SiHa and HeLa cell growth. The inhibition of cell growth was associated with a decrease in the expression of both stable and total PCNA and Ki-67, a proliferation marker whose expression may predict survival in uterine cervical carcinoma. TUNEL assay, flow cytometry with annexin-V-fluorescein, and morphological analysis indicated that iron chelation also induced a time- and dose-dependent apoptosis of both cell lines. This apoptotic effect was prevented by the addition of exogenous iron. CONCLUSION: These results show that iron chelation inhibits the growth and induces the apoptosis of HPV-positive carcinoma cells. This suggests that iron chelators may represent a potential therapeutic approach for the management of cervical carcinoma.
Asunto(s)
Deferoxamina/farmacología , Quelantes del Hierro/farmacología , Piridonas/farmacología , Neoplasias del Cuello Uterino/patología , Apoptosis/efectos de los fármacos , División Celular/efectos de los fármacos , Deferiprona , Femenino , Fase G1/efectos de los fármacos , Inhibidores de Crecimiento/farmacología , Células HeLa , Humanos , Papillomaviridae/clasificación , Papillomaviridae/metabolismo , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/metabolismo , Infecciones por Papillomavirus/virología , Fase de Descanso del Ciclo Celular/efectos de los fármacos , Células Tumorales Cultivadas , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/metabolismo , Infecciones Tumorales por Virus/virología , Neoplasias del Cuello Uterino/tratamiento farmacológico , Neoplasias del Cuello Uterino/virologíaRESUMEN
Persistent oncogenic human papillomavirus (HPV) infection is associated with cervical dysplasia. Cofactors, such as nutrient status, may be required for the progression of HPV infection to neoplasia. HPV DNA methylation patterns in vitro have been shown to be associated with viral transcriptional activity. Folate, vitamin B12, vitamin B6, and methionine may function to prevent cervical cancer through their role in DNA methylation. This study was conducted to examine the relationship of dietary intake of folate, vitamin B12, vitamin B6, and methionine, as well as circulating levels of folate and vitamin B12 to HPV persistence. Oncogenic HPV status was determined at baseline and at approximately 3 and 9 months postbaseline. Multivariate logistic regression analysis was used to determine the adjusted odds ratios for persistent HPV infection associated with each tertile of individual nutrient among 201 women with a persistent or intermittent HPV infection. Circulating vitamin B12 levels were inversely associated with HPV persistence (P for trend, 0.037) after adjusting for age, age at first intercourse, marital status, cigarette smoking status, race, and body mass index. In addition, women with circulating levels in the highest tertile (>493.2 pg/ml) of vitamin B12 were less likely to have a persistent infection (adjusted odds ratio = 0.4; 95% confidence interval = 0.17-0.96). No significant associations were observed between HPV persistence and dietary intake of folate, vitamin B12, vitamin B6, or methionine from food alone or from food and supplements combined or from circulating folate. These data suggest a role for circulating vitamin B12 in early cervical carcinogenesis.
Asunto(s)
Metilación de ADN , ADN Viral , Papillomaviridae/patogenicidad , Infecciones por Papillomavirus/complicaciones , Infecciones Tumorales por Virus/complicaciones , Neoplasias del Cuello Uterino/virología , Vitamina B 12/sangre , Adolescente , Adulto , Transformación Celular Neoplásica , Estudios de Cohortes , Femenino , Humanos , Estado Nutricional , Oportunidad Relativa , Papillomaviridae/genética , Análisis de Regresión , Neoplasias del Cuello Uterino/etiologíaRESUMEN
OBJECTIVE: Cervical intraepithelial neoplasia (CIN), a common condition among HIV-infected women, has been linked to HIV load and immune status. Highly active antiretroviral therapy (HAART) improves immunologic and virologic status. This study was undertaken to determine the relationship between HAART use and CIN. DESIGN: Cohort study. The Women's Interagency HIV Study (WIHS) in five cities in the USA (Bronx/Manhattan, New York; Brooklyn, New York; Chicago, Illinois; Los Angeles, California; San Francisco Bay area, California; Washington, District of Columbia). METHODS: HIV-infected women were followed every 6 months with Papanicolaou smears and cervicovaginal lavage for human papillomavirus (HPV) DNA testing. To characterize exposures that changed over time and to capture the dynamic nature of cytologic changes, Papanicolaou smear findings from each participant's consecutive visits were defined as a pair. We determined the proportion of all pairs that exhibited either regression or progression, according to HAART exposure, HPV results and Papanicolaou smear status. As participants could contribute multiple pairs, inferences were based on robust methods to adjust for correlated observations. RESULTS: Women with persistent HPV infection were more likely to have progression of their lesions. After adjustment for CD4 cell count and Papanicolaou smear status, women on HAART were 40% (95% confidence interval, 4-81%) more likely to demonstrate regression and less likely (odds ratio, 0.68; 95% confidence interval, 0.52-0.88) to demonstrate progression CONCLUSIONS: HAART altered the course of HPV disease in HIV-infected women, reducing progression and increasing regression. As HPV disease is a common sex-specific manifestation of HIV disease this effect of HAART would be a major additional benefit from this modality of therapy.
Asunto(s)
Terapia Antirretroviral Altamente Activa , Cuello del Útero/patología , Infecciones por VIH/complicaciones , Infecciones por Papillomavirus/tratamiento farmacológico , Infecciones Tumorales por Virus/tratamiento farmacológico , Displasia del Cuello del Útero/tratamiento farmacológico , Adolescente , Recuento de Linfocito CD4 , Cuello del Útero/citología , Cuello del Útero/virología , Estudios de Cohortes , ADN Viral/análisis , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , VIH-1/fisiología , Humanos , Prueba de Papanicolaou , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/virología , Resultado del Tratamiento , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/patología , Infecciones Tumorales por Virus/virología , Frotis Vaginal , Displasia del Cuello del Útero/complicaciones , Displasia del Cuello del Útero/patologíaAsunto(s)
Antineoplásicos/uso terapéutico , Inmunosupresores/uso terapéutico , Linfoma no Hodgkin/prevención & control , Complicaciones Posoperatorias/prevención & control , Sirolimus/uso terapéutico , Inmunología del Trasplante , Animales , Ensayos Clínicos Fase II como Asunto , Evaluación Preclínica de Medicamentos , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/inmunología , Humanos , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Linfoma no Hodgkin/etiología , Ratones , Metástasis de la Neoplasia , Complicaciones Posoperatorias/etiología , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/inmunología , Activación ViralRESUMEN
Previous observational epidemiologic studies of folate and cervical cancer, as well as folate supplementation trials for cervical dysplasia, have produced mixed results. We examined the relationship between serum and RBC folate and incident invasive cervical cancer in a large, multicenter, community-based case-control study. Detailed in-person interviews were conducted, and blood was drawn at least 6 mo after completion of cancer treatment from 51% of cases and 68% of controls who were interviewed. Blood folate was measured with both microbiologic and radiobinding assays. Included in the final analyses were 183 cases and 540 controls. Logistic regression was used to control for all accepted risk factors, including age, sexual behavior, smoking, oral contraceptive use, Papanicolaou smear history and human papillomavirus (HPV)-16 serology. For all four folate measures, the geometric mean in cases was lower than in controls (e.g., 11.6 vs. 13.0 nmol/L, P < 0.01 for the serum radiobinding assay). Folate measures using microbiologic and radiobinding assays were correlated (serum: r = 0.90; RBC: r = 0.77). For serum folate, multivariate-adjusted odds ratios (OR) in the lowest vs. highest quartile were 1.3 [95% confidence interval (CI) = 0.8--2.9] and 1.6 (0.9--2.9), using the microbiologic and radiobinding assays, respectively. For RBC folate, comparable OR were 1.2 (0.6--2.2) and 1.5 (0.8--2.7). Similar risks were obtained when restricting analyses to subjects with a history of HPV infection. Thus, low serum and RBC folate were each moderately, but nonsignificantly, associated with increased invasive cervical cancer risk. These findings support a role for one-carbon metabolism in the etiology of cervical cancer.
Asunto(s)
Adenocarcinoma/sangre , Carcinoma de Células Escamosas/sangre , Ácido Fólico/sangre , Neoplasias del Cuello Uterino/sangre , Adenocarcinoma/epidemiología , Adenocarcinoma/etiología , Adenocarcinoma/patología , Adulto , Anciano , Anticuerpos Antivirales/sangre , Técnicas Bacteriológicas , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/etiología , Carcinoma de Células Escamosas/patología , Estudios de Casos y Controles , Eritrocitos/química , Femenino , Humanos , Entrevistas como Asunto , Persona de Mediana Edad , Invasividad Neoplásica , Oportunidad Relativa , Papillomaviridae/inmunología , Infecciones por Papillomavirus/sangre , Infecciones por Papillomavirus/complicaciones , Análisis de Regresión , Factores de Riesgo , Infecciones Tumorales por Virus/sangre , Infecciones Tumorales por Virus/complicaciones , Estados Unidos/epidemiología , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/etiología , Neoplasias del Cuello Uterino/patologíaRESUMEN
BACKGROUND: The presence of lymphangiectasis without the characteristic spindle cell proliferation may lead to diagnostic difficulties in Kaposi's sarcoma. Although the literary data mention that the lymphangioma-like tumors may occur in Kaposi's sarcoma, there have been few specific reports and case presentations published. OBSERVATIONS: A case of lymphangioma-like Kaposi's sarcoma in association with IgG/lambda type paraproteinaemia is reported in a 60-year-old man. The HSV8 DNA sequence could be detected by PCR analysis from lesional skin. CONCLUSION: The beneficial effect of alpha-2 interferon (4.5 million units per week) combined with retinoic treatment (0.5 mg/body weight of isotretinoin) caused the regression of the skin rashes while improving the values of immunological tests (T cell function, quantity of paraproteins). The patient's improved general condition and the ameliorating immunological parameters were due to the combination of two regimens applied in a low-dose the alpha-2 interferon (tumor regression) and the oral isotretinoid (antitumor activity, reduction of IL-6 receptor display) treatment.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antineoplásicos/uso terapéutico , Antivirales/uso terapéutico , Interferón-alfa/uso terapéutico , Isotretinoína/uso terapéutico , Sarcoma de Kaposi/terapia , Neoplasias Cutáneas/terapia , Terapia Combinada , ADN Viral/aislamiento & purificación , Herpesvirus Humano 8/aislamiento & purificación , Humanos , Cadenas lambda de Inmunoglobulina/sangre , Linfangiectasia/etiología , Masculino , Persona de Mediana Edad , Paraproteinemias/etiología , Reacción en Cadena de la Polimerasa , Receptores de Interleucina-6/análisis , Sarcoma de Kaposi/complicaciones , Sarcoma de Kaposi/tratamiento farmacológico , Sarcoma de Kaposi/patología , Sarcoma de Kaposi/virología , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Infecciones Tumorales por Virus/complicaciones , Infecciones Tumorales por Virus/tratamiento farmacológico , Infecciones Tumorales por Virus/terapia , Infecciones Tumorales por Virus/virologíaRESUMEN
A. Storey et al. [Nature (Lond.), 393: 229-234, 1998)] reported a 7-fold increased risk of cervical cancer associated with having an Arg/Arg polymorphism at codon 72 of p53 compared with the Pro/Arg heterozygotes (odds ratio, 7.4; 95% confidence interval, 2.1-29.4). Complementary in vitro studies suggested that the HPV E6 oncoprotein more readily targets the arginine form, as opposed to the proline form, of p53 for degradation. We investigated the impact of this polymorphism in a population-based case-control study of invasive cervical cancer. Using a PCR assay to detect the p53 codon 72 polymorphism, we tested blood samples from 111 women with invasive squamous cell cancer of the cervix identified by a population-based registry and 164 random-digit telephone-dialed controls. The distribution of the genotype among control women was 38% heterozygous, 7% proline homozygous, and 55% arginine homozygous, and among the cases was 38%, 6%, and 56%, respectively. There was no increased risk of squamous cell invasive cervical cancer associated with homozygosity for the arginine allele (odds ratio, 1.0; 95% confidence interval, 0.6-1.7). Furthermore, there was no modification of this result by human papillomavirus (HPV) DNA status of the tumor, age, or smoking status. Among controls, there was no association between the polymorphism and HPV-16 L1 seropositivity. However, among case subjects, the codon 72 polymorphism may be related to HPV 16L1 seropositivity status.
Asunto(s)
Carcinoma de Células Escamosas/genética , Genes p53/genética , Invasividad Neoplásica , Papillomaviridae , Infecciones por Papillomavirus/complicaciones , Polimorfismo Genético , Infecciones Tumorales por Virus/complicaciones , Neoplasias del Cuello Uterino/genética , Adulto , Arginina , Carcinoma de Células Escamosas/etiología , Carcinoma de Células Escamosas/patología , Codón/genética , Femenino , Humanos , Persona de Mediana Edad , Prolina , Neoplasias del Cuello Uterino/etiología , Neoplasias del Cuello Uterino/patologíaRESUMEN
Human papillomaviruses (HPV) are increasingly recognised as important human carcinogens. The best established association with human malignancy is that of high-risk mucosal HPV types and anogenital cancer. HPV-induced transformation of anogenital epithelia has been the subject of intense research which has identified the cellular tumour suppressor gene products, p53 and pRB, as important targets for the viral oncoproteins E6 and E7 respectively. Certain HPV types are also strongly associated with the development of non-melanoma skin cancer in the inherited disorder epidermodysplasia verruciformis (EV). However, in contrast with anogenital malignancy the oncogenic mechanisms of EV-HPV types remain uncertain, and there appears to be a crucial additional requirement for ultraviolet radiation. Cutaneous HPV types in the general population are predominantly associated with benign viral warts, but a role in non-melanoma skin cancer has recently been postulated. Polymerase chain reaction based HPV detection techniques have shown a high prevalence of HPV DNA, particularly in skin cancers from immunosuppressed patients and to a lesser extent in malignancies from otherwise immunocompetent individuals. No particular HPV type has yet emerged as predominant, and the role of HPV in cutaneous malignancy is unclear at present. It remains to be established whether HPV plays an active or purely a passenger role in the evolution of non-melanoma skin cancer.